Home This week in gene and cell therapy - 10 August 2018 Gene and cell therapy headlines 6 - 10 August Oxford Biomedica and Boehringer Ingelheim to partner with UK Cystic Fibrosis Gene Therapy Consortium EvolvR, a new CRISPR based system, drives locus specific mutagenesis Regeneron and Bluebird bio enter partnership to develop anti-cancer cell therapies Akouos raises funds to take gene therapy for hearing loss into the clinic Spark releases data from haemophilia a trial and aims to move into phase 3 Allergan to co-develop and co-commercialise Editas gene therapy for retinal disorder Sarepta acquires rights to Lacerta Therapeutics CNS gene therapy Regenxbio releases promising phase I data for wet AMD gene therapy Astellas increases gene therapy presence by acquiring Quethera